AGENDA

7:45AM
Registration and continental breakfast

8:30 am
Welcome and introduction
Edward Miller, M.D.
Dean and CEO
Johns Hopkins Medicine

Overview of brain science at johns hopkins
John W. Griffin, M.D.
Professor, Departments of Neurology, Neuroscience, and Pathology
Director, Brain Science Institute

Richard L. Huganir, Ph.D.
Professor and Director, Department of Neuroscience
Co-Director, Brain Science Institute

brain science Institute Neurotranslation program
Jeffrey D. Rothstein, M.D., Ph.D.
Professor, Departments of Neurology and Neuroscience
Co-Director, Brain Science Institute
Director, Robert Packard Center for ALS Research

9:00 am
pharma perspective: state of cns drug development
Panel talk and discussion
Moderator:
Solomon H. Snyder, M.D.
Distinguished Service Professor of Neuroscience, Pharmacology, and Psychiatry
Johns Hopkins University

Speakers:
Robert Pacifici, Ph.D.
Chief Scientific Advisor,  Drug Discovery & Development
CHDI Foundation

William Z. Potter, M.D., Ph.D.
Vice President, Translational Neuroscience
Merck & Co.

Frank S. Walsh, Ph.D.
Executive Vice President, Discovery Research
Wyeth Research

10:15 am
venture philanthropy : new approaches to drug development & building partnerships
Panel talk and discussion
Moderator:
Hamilton Moses, III, M.D.
Chairman
Alerion Advisors, LLC and the Alerion Institute

Speakers:
Russell L. Bromley, Ph.D.
Chief Operating Officer
Myelin Repair Foundation

Hamilton Moses, III, M.D.
Chairman
Alerion Advisors, LLC and the Alerion Institute

Todd Sherer, Ph.D.
Vice President, Research Programs
Michael J. Fox Foundation

11:30 Am-12:15 Pm
Poster session (Showcasing Hopkins’ technologies available for licensing and commercialization)

12:15 Pm-1:00 Pm
Lunch and Lecture
OVERVIEW OF SCIENCE AND TECHNOLOGY PARK AT JOHNS HOPKINS
Frank C. Wuest
President
Forest City Science and Technology Group

1:00-1:30 PM
BREAK and poster session

1:30 pm
current state of neurodegenerative diseases, schizophrenia and depression

neurodegenerative disease, neuropathy, and pain
Ahmet Hoke, M.D., Ph.D.
Associate Professor, Departments of Neurology and Neuroscience
Director, Neuromuscular Division

Ted Dawson, M.D., Ph.D.
Professor, Departments of Neurology and Neuroscience
Director, Neuroregeneration and Repair Program, Institute for Cell Engineering

Alzheimer's Disease
Donald Price, M.D.
Professor, Departments of Pathology, Neurology, and Neuroscience
Director, Division of Neuropathology
Vice Chairman for Research, Department of Pathology
Director, Alzheimer's Disease Research Center

Schizophrenia and depression
Christopher A. Ross, M.D., Ph.D.
Professor, Departments of Psychiatry, Neurology, and Neuroscience
Director, Division of Neurobiology

2:45 pm
overcoming current limitations of cns drug discovery and development
Panel talk and discussion
Moderator:
Michael J. Haas, M.Sc.
Senior Writer
BioCentury

Speakers:
Howard M. Fillit, M.D.
Executive Director
The Alzheimer's Drug Discovery Foundation

Franz F. Hefti, Ph.D.
Chief Scientific Officer
Avid Radiopharmaceuticals

Kenneth J. Rhodes, Ph.D.
Vice President, Discovery Neurobiology
Biogen Idec

4:00-4:15 PM
break

4:15 pm
challenges of funding early stage neuroscience companies
Panel talk and discussion
Moderator:
James N. Campbell, M.D.
Professor, Department of Neurosurgery, Director Blaustein Pain Treatment Center
Principal Professional Staff, Applied Physics Laboratory

Speakers:
James Barrett, Ph.D.
General Partner
New Enterprise Associates

Mark A. Cochran, Ph.D.
Acting CEO
Microbix Biosystems, Inc.

Roger J. Quy, Ph.D.
General Partner
Technology Partners

5:30 pm
adjourn
Wine Reception with hors d'oeuvres

Register now